Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Osteoprotegerin and inflammation.

N Saidenberg Kermanac'h1, Natacha Bessis, M Cohen-Solal

  • 1Groupe de Recherches en Immunopathologie et Immunointervention, UPRES EA-3408, Formation associée Claud Bernard and Service de Rhumatologie, Hôpital Avicenne, AH-AP, Université Paris 13, UFR Léonard-de Vinci, Bobigny, France.

European Cytokine Network
|July 9, 2002
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Impact of JAK-inhibition on pain and biphasic P2X7R expression on CD4<sup>+</sup> T cells in experimental arthritis.

Scientific reports·2026
Same author

Safety and immunogenicity of PPV-06, an active anti-IL-6 immunotherapy targeting low-grade inflammation against knee osteoarthritis: a randomized, double-blind, placebo-controlled, clinical phase 1 study.

Nature communications·2025
Same author

Intra-articular sustained-release colchicine is efficacious in an inflammatory arthritis rat model.

RMD open·2025
Same author

Short telomere length is associated with accelerated lung disease progression in rheumatoid arthritis-associated interstitial lung disease.

The European respiratory journal·2025
Same author

Cytotoxic Response of CD4<sup>+</sup> T Cells Orchestrated by SLAMF4 in Rheumatoid Arthritis.

Arthritis & rheumatology (Hoboken, N.J.)·2025
Same author

Impairment of regulatory T cell stability in axial spondyloarthritis: role of EZH2 and pSTAT5.

Frontiers in immunology·2024
Same journal

Co-expression of CCR7 and H3K9me3 identifies aggressive B-cell lymphoma with bone marrow infiltration and poor prognosis.

European cytokine network·2026
Same journal

Re-evaluating cytokine storm syndromes: dysregulated host defense or contextual immune adaptation?

European cytokine network·2026
Same journal

Propolis as a potential modulator of aryl hydrocarbon receptor signaling in inflammation.

European cytokine network·2026
Same journal

Association between interleukin-6 promoter polymorphisms and osteoporosis in javanese postmenopausal women.

European cytokine network·2026
Same journal

Study of interferon-stimulated gene 15 expression in the medulloblastoma context.

European cytokine network·2026
Same journal

Astilbin ameliorates propranolol-induced psoriasis-like lesions through restoring Th17/Treg immune homeostasis in lymph nodes.

European cytokine network·2026
See all related articles

The RANKL/RANK/OPG system regulates bone metabolism and immunity. Activated T cells expressing RANKL contribute to inflammatory bone resorption, suggesting OPG as a potential therapeutic for diseases like rheumatoid arthritis.

Area of Science:

  • Bone Biology and Immunology
  • Inflammation and Autoimmunity

Background:

  • The RANK, RANKL, and OPG system is crucial for bone metabolism.
  • RANKL binding to RANK drives osteoclast differentiation and bone resorption.
  • OPG inhibits bone resorption by binding RANKL.

Purpose of the Study:

  • To define the role of RANKL, RANK, and OPG in inflammatory processes.
  • To investigate the RANK system's impact on immune modulation and bone resorption associated with inflammation.

Main Methods:

  • Analysis of RANKL expression in activated T cells.
  • Examination of RANKL knockout mice for immunological and bone phenotypes.
  • Investigation of cytokine effects (TNF-alpha, IL-1, IL-17, IL-4, IL-10) on the RANK system.

Related Experiment Videos

Main Results:

  • RANKL knockout mice exhibit immunological abnormalities and osteopetrosis.
  • Activated T cells express RANKL, promoting osteoclastogenesis.
  • Cytokines like TNF-alpha and IL-17 enhance inflammation and bone resorption, while OPG, IL-4, and IL-10 inhibit both.
  • RANKL expression by T cells in rheumatoid synovium correlates with bone erosion.

Conclusions:

  • The RANK system plays a significant role in modulating the immune system and inflammatory bone resorption.
  • Activated T cells contribute to bone erosion in inflammatory diseases like rheumatoid arthritis via RANKL.
  • OPG holds therapeutic potential for blocking the RANKL/RANK system in inflammatory bone diseases.